Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.

Chemico-biological interactions 20130225

Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

British journal of haematology 20120901

Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.

Cancer 20120801

Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.

Journal of surgical oncology 20120801

Mesna-induced photodistributed dermatosis.

Clinical and experimental dermatology 20120601

Pharmacological modulation of oxidative stress response in minimally invasive surgery: systematic review.

Surgical laparoscopy, endoscopy & percutaneous techniques 20120601

In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna.

Journal of clinical pharmacology 20120401

Coordination of methyl coenzyme M and coenzyme M at divalent and trivalent nickel cyclams: model studies of methyl coenzyme M reductase active site.

Inorganic chemistry 20120319

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.

Annals of oncology : official journal of the European Society for Medical Oncology 20120301

Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20120301

Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.

Journal of pediatric hematology/oncology 20120301

Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Cancer 20120215

Interleukin-4 modulates the inflammatory response in ifosfamide-induced hemorrhagic cystitis.

Inflammation 20120201

Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy.

Journal of pediatric surgery 20120201

The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice.

British journal of pharmacology 20120101

Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient.

The breast journal 20120101

Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlates.

Clinical cancer research : an official journal of the American Association for Cancer Research 20111215

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Separation and recycling of nanoparticles using cloud point extraction with non-ionic surfactant mixtures.

Journal of colloid and interface science 20111115

Determination of the sodium 2-mercaptoethanesulfonate based on surface-enhanced Raman scattering.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111015

Endoscopic submucosal dissection with a flexible Maryland dissector: randomized comparison of mesna and saline solution for submucosal injection (with videos).

Gastrointestinal endoscopy 20111001

Fixed drug eruption caused by mesna.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20111001

Accumulation of BNP7787 in human renal proximal tubule cells.

Journal of pharmaceutical sciences 20110901

Intein lacking conserved C-terminal motif G retains controllable N-cleavage activity.

The FEBS journal 20110901

Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.

Journal of pediatric hematology/oncology 20110801

Mesna preserves hepatocyte regenerating capacity following liver radiofrequency ablation under Pringle maneuver.

The Journal of surgical research 20110701

Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.

The journal of obstetrics and gynaecology research 20110601

2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.

Free radical biology & medicine 20110601

The effect of N-acetylcysteine on the antitumor activity of ifosfamide.

Canadian journal of physiology and pharmacology 20110501

Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder.

Cancer chemotherapy and pharmacology 20110401

MESNA (sodium 2-mercaptoethanesulfonate) for prevention of contrast medium-induced nephrotoxicity - controlled trial.

Clinical nephrology 20110401

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer.

Cancer chemotherapy and pharmacology 20110301

Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.

Japanese journal of clinical oncology 20110301

Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.

European journal of cancer (Oxford, England : 1990) 20110301

Chemical inhibitors of methanogenesis and putative applications.

Applied microbiology and biotechnology 20110301

Separating nanoparticles from microemulsions.

Journal of colloid and interface science 20110215

Structural basis for carbon dioxide binding by 2-ketopropyl coenzyme M oxidoreductase/carboxylase.

FEBS letters 20110204

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.

Cancer chemotherapy and pharmacology 20110201

Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis.

Archives of toxicology 20110101

Assay of methylotrophic methyltransferases from methanogenic archaea.

Methods in enzymology 20110101

Methyl-coenzyme M reductase from Methanothermobacter marburgensis.

Methods in enzymology 20110101

2-oxoacid metabolism in methanogenic CoM and CoB biosynthesis.

Methods in enzymology 20110101

[Nephropathy following administration of angiogenesis inhibitors].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101

[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy].

Annales de dermatologie et de venereologie 20110101

Chemoselective protein and peptide immobilization on biosensor surfaces.

Methods in molecular biology (Clifton, N.J.) 20110101

Electron transport in acetate-grown Methanosarcina acetivorans.

BMC microbiology 20110101

Detection of organometallic and radical intermediates in the catalytic mechanism of methyl-coenzyme M reductase using the natural substrate methyl-coenzyme M and a coenzyme B substrate analogue.

Biochemistry 20101228

Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20101201

Shotgun proteomics of Xanthobacter autotrophicus Py2 reveals proteins specific to growth on propylene.

Archives of microbiology 20101101

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

Continuously improving ifosfamide/mesna: a winning combination.

Pediatric blood & cancer 20101001

Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.

Urology 20101001

Structural insight into methyl-coenzyme M reductase chemistry using coenzyme B analogues .

Biochemistry 20100907

Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.

Medical oncology (Northwood, London, England) 20100901

BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.

Molecular cancer therapeutics 20100901

Neuroblastoma in an adult: case report.

Revista medica de Chile 20100901

Mechanism of inhibition of aliphatic epoxide carboxylation by the coenzyme M analog 2-bromoethanesulfonate.

The Journal of biological chemistry 20100813

Chemically assisted submucosal injection facilitates endoscopic submucosal dissection of gastric neoplasms.

Endoscopy 20100801

Effect of thiol drugs on tert-butyl hydroperoxide induced luminol chemiluminescence in human erythrocytes, erythrocyte lysate, and erythrocyte membranes.

Chemico-biological interactions 20100730

The key nickel enzyme of methanogenesis catalyses the anaerobic oxidation of methane.

Nature 20100603

MESNA for chemically assisted tissue dissection.

Expert opinion on investigational drugs 20100601

Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles.

Small (Weinheim an der Bergstrasse, Germany) 20100507

Raman characterization of monolayers formed from mixtures of sodium 2-mercaptoethanesulfonate and various aromatic mercapto-derivative bases.

The journal of physical chemistry. B 20100422

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.

Cancer chemotherapy and pharmacology 20100401

Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100401

Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study.

Anti-cancer drugs 20100301

Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.

Cancer chemotherapy and pharmacology 20100201

Methanogenesis by Methanosarcina acetivorans involves two structurally and functionally distinct classes of heterodisulfide reductase.

Molecular microbiology 20100201

Stability of mesna in ReadyMed infusion devices.

The Annals of pharmacotherapy 20100101

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

Arthritis and rheumatism 20100101

Successful treatment of metastatic malignant fibrous histiocytoma of the kidney.

Urologia internationalis 20100101

Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.

Pediatric blood & cancer 20091215

Convergent evolution of coenzyme M biosynthesis in the Methanosarcinales: cysteate synthase evolved from an ancestral threonine synthase.

The Biochemical journal 20091210

Immediate type hypersensitivity to chemotherapeutic agents in pediatric patients.

Asian Pacific journal of allergy and immunology 20091201

Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.

The Journal of pharmacology and experimental therapeutics 20091101

Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report.

Journal of pediatric hematology/oncology 20091101

Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate.

Bioconjugate chemistry 20090819

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

Annals of oncology : official journal of the European Society for Medical Oncology 20090801

Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.

Anticancer research 20090801

alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases.

American journal of physiology. Lung cellular and molecular physiology 20090501

Intraductal administration of a mucolytic agent with gland massages: a suitable conservative treatment of acute obstructive parotitis.

Southern medical journal 20090501

Impaired liver regeneration following partial hepatectomy using the Pringle maneuver: Protective effect of mesna.

Journal of gastroenterology and hepatology 20090401

Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401

Mesna protects splanchnic organs from oxidative stress induced by pneumoperitoneum.

Surgical endoscopy 20090301

Chemotherapy for Langerhans cell sarcoma.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090301

Determination and applications of the molar absorptivity of phenolic adducts with captopril and mesna.

Journal of agricultural and food chemistry 20090225

Undifferentiated sarcoma of the maxillary sinus: report of a rare case in an adult.

Auris, nasus, larynx 20090201

Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen.

Therapeutic drug monitoring 20090201

Temporary remission of a multirecurrent cystosarcoma phyllodes of the breast by using continuous chemotherapy.

Plastic and reconstructive surgery 20090201

Inhibition of human sperm respiration by 4-hydroperoxycyclophosphamide and protection by mesna and WR-1065.

Fertility and sterility 20090101

Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.

Medical oncology (Northwood, London, England) 20090101

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090101

Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.

Blood purification 20090101

Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester.

BMC biotechnology 20090101

Segmental isotopic labeling of proteins for nuclear magnetic resonance.

Methods in enzymology 20090101

Effectiveness of a mucolythic agent as a local adjuvant in revision lumbar spine surgery.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20081201

Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.

Journal of pediatric surgery 20081201

Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.

Lung cancer (Amsterdam, Netherlands) 20081101

Coordination and binding geometry of methyl-coenzyme M in the red1m state of methyl-coenzyme M reductase.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20081101

A 50-year-old man with burkitt lymphoma.

Brain pathology (Zurich, Switzerland) 20081001

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001

Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20080901

Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Clinical journal of the American Society of Nephrology : CJASN 20080701

Multidisciplinary management of metastatic sarcoma.

The Surgical clinics of North America 20080601

In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.

Pediatric nephrology (Berlin, Germany) 20080401

Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats.

American journal of obstetrics and gynecology 20080401

Archaeoglobus infectus sp. nov., a novel thermophilic, chemolithoheterotrophic archaeon isolated from a deep-sea rock collected at Suiyo Seamount, Izu-Bonin Arc, western Pacific Ocean.

International journal of systematic and evolutionary microbiology 20080401

Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report.

Military medicine 20080401

Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.

Pediatric blood & cancer 20080301

Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.

Pediatric blood & cancer 20080301

Chemically assisted endoscopic mechanical submucosal dissection by using mesna.

Gastrointestinal endoscopy 20080301

Full-dose ifosfamide can be safely administered to outpatients.

Pediatric blood & cancer 20080201

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.

Pediatric blood & cancer 20080201

Prophylaxis with mesna prevents oxidative stress induced by ischemia reperfusion in the intestine via inhibition of nuclear factor-kappaB activation.

Journal of gastroenterology and hepatology 20080201

Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells.

European journal of medicinal chemistry 20080101

Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats.

Journal of cancer research and clinical oncology 20080101

Off-label use of MESNA in Dupuytren's disease.

Medical hypotheses 20080101

Amplification of molecular information through self-assembly: nanofibers formed from amino acids and cyanine dyes by extended molecular pairing.

Angewandte Chemie (International ed. in English) 20080101

Mediastinal sarcoma with deviated tracheal anatomy.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080101

Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080101

Stage IV primitive-appearing sinus and orbital rhabdomyosarcoma presenting in a 68-year-old female previously treated for breast cancer.

Orbit (Amsterdam, Netherlands) 20080101

Protein-cross-linked polymeric materials through site-selective bioconjugation.

Angewandte Chemie (International ed. in English) 20080101

Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality.

Scandinavian journal of rheumatology 20080101

Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.

Journal of minimally invasive gynecology 20080101

One-step refolding and purification of disulfide-containing proteins with a C-terminal MESNA thioester.

BMC biotechnology 20080101

[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].

Ai zheng = Aizheng = Chinese journal of cancer 20071201

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

Gynecologic oncology 20071101

The effects of viscero-somatic interactions on thalamic mast cell recruitment in cystitic rats.

Journal of neuroimmunology 20071001

Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.

Pediatric blood & cancer 20070901

Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.

Cell biology and toxicology 20070901

Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.

Pediatric blood & cancer 20070801

Expressed protein ligation using an N-terminal cysteine containing fragment generated in vivo from a pelB fusion protein.

Protein expression and purification 20070801

Mesna as a nonvitamin intervention to lower plasma total homocysteine concentration: implications for assessment of the homocysteine theory of atherosclerosis.

Journal of clinical pharmacology 20070801

Cytoprotective agents used in the treatment of patients with cancer.

Seminars in oncology nursing 20070801

The effect of short-term intensive chemotherapy on reactivation of tuberculosis.

Annals of oncology : official journal of the European Society for Medical Oncology 20070701

Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.

Pediatric nephrology (Berlin, Germany) 20070601

A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.

Gynecologic oncology 20070501

Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.

Cancer chemotherapy and pharmacology 20070401

Ifosfamide toxicity in cultured proximal renal tubule cells.

Pediatric nephrology (Berlin, Germany) 20070301

Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy.

Gynecologic oncology 20070101

The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation 20070101

[Study on interaction of acetaldehyde with thioalcohols by infrared spectroscopy].

Biomeditsinskaia khimiia 20070101

Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.

Kidney international 20061101

A model of hemorrhagic cystitis induced with acrolein in mice.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061101

[Malignant fibrous histiocytoma of the retroperitoneum--review of clinical course and histopathology].

Hinyokika kiyo. Acta urologica Japonica 20061001

Mesna protects intestinal mucosa from ischemia/reperfusion injury.

The Journal of surgical research 20060801

Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.

The Journal of laryngology and otology 20060601

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.

Molecular nutrition & food research 20060501

Successful treatment via chemotherapy and surgical resection of a femoral hemangiopericytoma with pulmonary metastasis.

Journal of pediatric hematology/oncology 20060401

[A case of secondary malignant lymphoma of the urinary bladder].

Hinyokika kiyo. Acta urologica Japonica 20060401

Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.

American journal of veterinary research 20060301

Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study.

Cancer investigation 20060201

[Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].

Zhonghua er ke za zhi = Chinese journal of pediatrics 20060201

Practical use of MESNA in atelectatic ears and adhesive otitis media.

ORL; journal for oto-rhino-laryngology and its related specialties 20060101

Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report.

Pediatric hematology and oncology 20060101

Adjuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group.

Tumori 20060101

Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats.

Indian journal of cancer 20060101

Retroperitoneal synovial sarcoma.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20060101

High-dose cyclophosphamide and MESNA infusion can cause acute atrial fibrillation.

American journal of hematology 20051101

Evidence for a metal-thiolate intermediate in alkyl group transfer from epoxypropane to coenzyme M and cooperative metal ion binding in epoxyalkane:CoM transferase.

Biochemistry 20051004

Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis.

American journal of physiology. Renal physiology 20051001

Primary angiosarcoma of the ovary: a case report of Stage I disease.

Gynecologic oncology 20051001

Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.

Gynecologic oncology 20050901

Alveolar soft part sarcoma: a rare and enigmatic entity.

Clinical orthopaedics and related research 20050901

In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesna.

Clinical cancer research : an official journal of the American Association for Cancer Research 20050901

Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.

Archives of toxicology 20050801

The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery.

International journal of radiation oncology, biology, physics 20050701

Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.

American journal of kidney diseases : the official journal of the National Kidney Foundation 20050701

Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620

Temperature dependence of methyl-coenzyme M reductase activity and of the formation of the methyl-coenzyme M reductase red2 state induced by coenzyme B.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20050601

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.

British journal of cancer 20050509

Doxorubicin-induced second degree and complete atrioventricular block.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20050501

A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.

Chemotherapy 20050501

Re: Comments on paper by Son et al.

Toxicology letters 20050410

Long-term results of dose density therapy in patients with aggressive lymphoma.

Annals of hematology 20050401

A rare case of breast sarcoma brain metastases.

Journal of neuro-oncology 20050401

Direct interaction of coenzyme M with the active-site Fe-S cluster of heterodisulfide reductase.

FEBS letters 20050314

Photoactivated luminescent CdSe quantum dots as sensitive cyanide probes in aqueous solutions.

Chemical communications (Cambridge, England) 20050221

Effect of the electrostatic interaction on the redox reaction of positively charged cytochrome C adsorbed on the negatively charged surfaces of acid-terminated alkanethiol monolayers on a Au(111) electrode.

Langmuir : the ACS journal of surfaces and colloids 20050215

Attenuation of bleomycin-induced lung fibrosis in rats by mesna.

European journal of pharmacology 20050210

Biological chemistry of naturally occurring thiols of microbial and marine origin.

Journal of natural products 20050201

Panniculitis induced by a chemotherapy regimen consisting of topotecan and cyclophosphamide.

Pediatric blood & cancer 20050101

High performance liquid chromatography analysis of MESNA (2-mercaptoethane sulfonate) in biological samples using fluorescence detection.

Biomedical chromatography : BMC 20050101

Protective effects of MESNA (2-mercaptoethane sulphonate) against acetaminophen-induced hepatorenal oxidative damage in mice.

Journal of applied toxicology : JAT 20050101

Protective effect of MESNA (2-mercaptoethane sulfonate) against hepatic ischemia/reperfusion injury in rats.

Surgery today 20050101

Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomas.

European journal of gynaecological oncology 20050101

Uterine liposarcoma in a young woman: a case report.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215

Aggressive mixed epithelial-stromal tumour of the kidney treated with chemotherapy and radiotherapy.

The Lancet. Oncology 20041201

High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.

Experimental oncology 20041201

Effects of ursolic acid, betulin and sulfur-containing compounds on mucin release from airway goblet cells.

Planta medica 20041201

Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.

Cancer chemotherapy and pharmacology 20041101

Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology 20041101

Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.

Radiation research 20041101

Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?

Annals of the rheumatic diseases 20041001

Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.

Pediatric blood & cancer 20041001

Mesna (2-mercaptoethane sulfonate) prevents ischemia/reperfusion induced renal oxidative damage in rats.

Life sciences 20040924

Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.

Cancer chemotherapy and pharmacology 20040901

2-Mercaptoethane sulfonate (MESNA) protects against burn-induced renal injury in rats.

Burns : journal of the International Society for Burn Injuries 20040901

Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner.

The Journal of surgical research 20040901

Probing the reactivity of Ni in the active site of methyl-coenzyme M reductase with substrate analogues.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20040901

[Soft tissue sarcoma: postoperative chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20040901

Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.

Biochemical pharmacology 20040801

Hyperbaric oxygen therapy for cyclophosphamide induced refractory hemorrhagic cystitis in a child.

The Journal of urology 20040801

Extraskeletal Ewing sarcoma of the diaphragm presenting with hemothorax.

The Annals of thoracic surgery 20040801

The stereoselectivity and catalytic properties of Xanthobacter autotrophicus 2-[(R)-2-Hydroxypropylthio]ethanesulfonate dehydrogenase are controlled by interactions between C-terminal arginine residues and the sulfonate of coenzyme M.

Biochemistry 20040601

Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.

British journal of cancer 20040419

Alveolar soft-part sarcoma responsive to intensive chemotherapy.

Journal of pediatric hematology/oncology 20040401

Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.

Leukemia & lymphoma 20040401

Primary omental synovial sarcoma: a case with cytogenetic confirmation.

Pathology 20040401

Extended total sacrectomy and reconstruction for sacral tumor.

Spine 20040315

Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats.

Phytotherapy research : PTR 20040201

BNP-7787 (BioNumerik/Baxter Oncology/Grelan).

IDrugs : the investigational drugs journal 20040101

Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients.

Medical oncology (Northwood, London, England) 20040101

The effect of cytoprotective agents in platinum anticancer therapy.

Metal ions in biological systems 20040101

Free reactive oxygen species and nephrotoxicity of contrast agents.

Kidney & blood pressure research 20040101

Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis.

Angiogenesis 20040101

[Financial assessment of device for the preparation of intravenous mixtures in hospital pharmacy].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20040101

Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: results of a single center in central anatolia.

Medical oncology (Northwood, London, England) 20040101

Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion.

Journal of clinical pharmacology 20031201

Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.

The Annals of pharmacotherapy 20031201

Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.

Clinical cancer research : an official journal of the American Association for Cancer Research 20031201

A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.

Haematologica 20031201

Two schedules of application for mesna and their influence on the thiol-metabolism.

International journal of clinical pharmacology and therapeutics 20031201

The structural determination of phosphosulfolactate synthase from Methanococcus jannaschii at 1.7-A resolution: an enolase that is not an enolase.

The Journal of biological chemistry 20031114

Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.

Bone marrow transplantation 20031101

Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis.

International journal of urology : official journal of the Japanese Urological Association 20031101

Chemically assisted capsulectomy in the rabbit model: a new approach.

Plastic and reconstructive surgery 20031001

The effectiveness of sodium 2-mercaptoethane sulfonate (mesna) in reducing capsular formation around implants in a rabbit model.

Plastic and reconstructive surgery 20031001

Pelvic primitive neuroectodermal tumor associated with a cluster of small round cell tumors: case report and review of current literature.

Gynecologic oncology 20031001

Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis.

The Journal of urology 20030901

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets.

Gynecologic oncology 20030901

Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.

Toxicology in vitro : an international journal published in association with BIBRA 20030801

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.

Clinical pharmacology and therapeutics 20030801

Biocatalytic conversion of epoxides.

Current opinion in biotechnology 20030801

Has 'MAID' made it in the management of high-risk soft-tissue sarcoma?

International journal of radiation oncology, biology, physics 20030715

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.

International journal of radiation oncology, biology, physics 20030715

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Cancer 20030715

Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705

Catalysis by methyl-coenzyme M reductase: a theoretical study for heterodisulfide product formation.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20030701

New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.

Cancer chemotherapy and pharmacology 20030701

The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.

Cancer chemotherapy and pharmacology 20030601

Vibrational spectroscopic studies of mesna and dimesna.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20030601

Pharmacokinetics of BNP7787 and its metabolite mesna in plasma and ascites: a case report.

Cancer chemotherapy and pharmacology 20030601

Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis.

Digestive diseases and sciences 20030601

Nickel uptake and utilization by microorganisms.

FEMS microbiology reviews 20030601

Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.

Cancer chemotherapy and pharmacology 20030501

Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.

Journal of pharmaceutical sciences 20030501

Chemically assisted dissection of tissues in laparoscopic excision of endometriotic cysts.

The Journal of the American Association of Gynecologic Laparoscopists 20030501

New chemotherapy agents in veterinary medicine.

The Veterinary clinics of North America. Small animal practice 20030501

Coenzyme B induced coordination of coenzyme M via its thiol group to Ni(I) of F430 in active methyl-coenzyme M reductase.

Journal of the American Chemical Society 20030430

Lack of effects of sodium 2-mercaptoethane sulfonate (mesna) on Ochratoxin A induced renal tumorigenicity following life-time oral administration of Ochratoxin A in DA and Lewis rats.

Toxicology letters 20030430

Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Cancer letters 20030410

Redox potentials of methanophenazine and CoB-S-S-CoM, factors involved in electron transport in Methanogenic archaea.

Chembiochem : a European journal of chemical biology 20030404

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.

Cancer 20030315

Coenzyme M binds to a [4Fe-4S] cluster in the active site of heterodisulfide reductase as deduced from EPR studies with the [33S]coenzyme M-treated enzyme.

FEBS letters 20030313

High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.

Pediatric hematology and oncology 20030301

Occupational airborne allergic contact dermatitis from mesna.

Contact dermatitis 20030301

Quantification of mesna and total mesna in kidney tissue by high-performance liquid chromatography with electrochemical detection.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030105

Bioenergetics of the formyl-methanofuran dehydrogenase and heterodisulfide reductase reactions in Methanothermobacter thermautotrophicus.

European journal of biochemistry 20030101

Aliphatic epoxide carboxylation.

Annual review of biochemistry 20030101

Expression of CD40 has no predictive value in soft tissue sarcomas.

Anticancer research 20030101

Dose finding of ifosfamide administered with a chronic two-week continuous infusion.

Oncology 20030101

Effects of subchronic ifosfamide-mesna treatment on testes and semen characteristics in the rabbit.

Reproductive toxicology (Elmsford, N.Y.) 20030101

Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.

Bone marrow transplantation 20021201

Structural basis for CO2 fixation by a novel member of the disulfide oxidoreductase family of enzymes, 2-ketopropyl-coenzyme M oxidoreductase/carboxylase.

Biochemistry 20021029

Ifosfamide-induced encephalopathy.

Southern medical journal 20021001

Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.

Clinical oncology (Royal College of Radiologists (Great Britain)) 20021001

Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.

Cancer 20020915

Abdominal aortic sarcoma: report of a case with long-term survival and review of the literature.

Annals of vascular surgery 20020901

Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.

Medical and pediatric oncology 20020901

Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.

Clinical lymphoma 20020901

Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065.

Drug metabolism and disposition: the biological fate of chemicals 20020801

Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.

Nature immunology 20020801

[Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].

Ai zheng = Aizheng = Chinese journal of cancer 20020801

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.

Cancer 20020715

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.

European journal of cancer (Oxford, England : 1990) 20020501

Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

Cancer chemotherapy and pharmacology 20020501

Polysulfonates derived from metal thiolate complexes as inhibitors of HIV-1 and various other enveloped viruses in vitro.

Antiviral chemistry & chemotherapy 20020501

Identification of coenzyme M biosynthetic phosphosulfolactate synthase: a new family of sulfonate-biosynthesizing enzymes.

The Journal of biological chemistry 20020419

Kinetic and microcalorimetric analysis of substrate and cofactor interactions in epoxyalkane:CoM transferase, a zinc-dependent epoxidase.

Biochemistry 20020416

The role of zinc in the methylation of the coenzyme M thiol group in methanol:coenzyme M methyltransferase from Methanosarcina barkeri.

European journal of biochemistry 20020401

Elucidation of methanogenic coenzyme biosyntheses: from spectroscopy to genomics.

Natural product reports 20020401

Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.

European journal of medical research 20020328

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.

Circulation 20020312

Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: excessive toxicity with a potentially active regimen.

Gynecologic oncology 20020301

Heterodisulfide reductase from Methanothermobacter marburgensis contains an active-site [4Fe-4S] cluster that is directly involved in mediating heterodisulfide reduction.

FEBS letters 20020213

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.

Cancer 20020201

The nickel enzyme methyl-coenzyme M reductase from methanogenic archaea: in vitro interconversions among the EPR detectable MCR-red1 and MCR-red2 states.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20020101

Cyclophosphamide and the urinary tract.

Internal medicine journal 20020101

Ewing's sarcoma of the mandible: a combined approach to treatment.

The Journal of clinical pediatric dentistry 20020101

U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.

The oncologist 20020101

Recombinant human interleukin-3 administered concomitantly with chemotherapy in patients with relapsed small cell lung cancer.

Journal of experimental therapeutics & oncology 20020101

Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101

Radioprotectants: current status and new directions.

Oncology 20020101

Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.

Drug metabolism and disposition: the biological fate of chemicals 20011101

Zinc-thiolate intermediate in catalysis of methyl group transfer in Methanosarcina barkeri.

Biochemistry 20011030

Identification of coenzyme M biosynthetic 2-phosphosulfolactate phosphatase. A member of a new class of Mg(2+)-dependent acid phosphatases.

European journal of biochemistry 20011001

[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].

Gan to kagaku ryoho. Cancer & chemotherapy 20011001

Postchemotherapy confusion.

Oncology nursing forum 20011001

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.

Cancer 20011001

Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria.

Urological research 20011001

Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.

The Journal of urology 20010901

Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.

American journal of clinical pathology 20010901

Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.

Journal of experimental & clinical cancer research : CR 20010901

Effect of mesna on lethal effect and hematological toxicity of taxol and vepeside in mice.

Bulletin of experimental biology and medicine 20010901

The management of intractable haematuria.

BJU international 20010801

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

International journal of radiation oncology, biology, physics 20010701

Intein-mediated ligation and cyclization of expressed proteins.

Methods (San Diego, Calif.) 20010701

Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.

European journal of haematology. Supplementum 20010701

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).

European journal of haematology. Supplementum 20010701

[Treatment of vasculitis with antineutrophil cytoplasmic autoantibodies (ACPN)].

Presse medicale (Paris, France : 1983) 20010630

Combination chemotherapy for extensive small cell lung cancer -- experience from India.

Lung cancer (Amsterdam, Netherlands) 20010501

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.

Annals of oncology : official journal of the European Society for Medical Oncology 20010501

Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.

Journal of pediatric hematology/oncology 20010501

Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection.

Journal of chromatography. A 20010420

Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection.

Journal of chromatography. B, Biomedical sciences and applications 20010405

[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20010401

Crystallization and preliminary X-ray analysis of a NADPH 2-ketopropyl-coenzyme M oxidoreductase/carboxylase.

Acta crystallographica. Section D, Biological crystallography 20010301

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301

Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010301

Immunoglobulin D myeloma presenting as an extraosseous soft tissue tumor.

Skeletal radiology 20010301

Characterization of a naturally occurring trans-splicing intein from Synechocystis sp. PCC6803.

Biochemistry 20010206

Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201

[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].

Revista espanola de medicina nuclear 20010201

Treatment of mandibular malignant fibrous histiocytoma during pregnancy.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20010201

Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.

Annals of oncology : official journal of the European Society for Medical Oncology 20010201

[Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives].

Onkologie 20010201

Characterization of the intramolecular electron transfer pathway from 2-hydroxyphenazine to the heterodisulfide reductase from Methanosarcina thermophila.

The Journal of biological chemistry 20010126

Biosynthesis of the methanogenic cofactors.

Vitamins and hormones 20010101

Variation in administration of cyclophosphamide and mesna in the treatment of childhood malignancies.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 20010101

The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin.

Anticancer research 20010101

[Development of cancer chemotherapy. Cytoprotective agents].

La Clinica terapeutica 20010101

[Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient].

Przeglad lekarski 20010101

Novel thiols of prokaryotes.

Annual review of microbiology 20010101

[Malignant Brenner tumor and transitional cell ovarian carcinoma--description of two cases].

Akusherstvo i ginekologiia 20010101

Methyl-coenzyme M formation in methanogenic archaea. Involvement of zinc in coenzyme M activation.

European journal of biochemistry 20000501

Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 19991001

A role for coenzyme M (2-mercaptoethanesulfonic acid) in a bacterial pathway of aliphatic epoxide carboxylation.

Proceedings of the National Academy of Sciences of the United States of America 19990720

Prevention of cyclophosphamide-induced hemorrhagic cystitis by glucose-mannose binding plant lectins.

The Journal of urology 19990601

The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities.

Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie 19990601

Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.

Leukemia 19971201

Crystal structure of methyl-coenzyme M reductase: the key enzyme of biological methane formation.

Science (New York, N.Y.) 19971121

Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.

Clinical cancer research : an official journal of the American Association for Cancer Research 19970901

Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.

Archivum immunologiae et therapiae experimentalis 19970101

Combined intravenous and oral mesna in outpatients treated with ifosfamide.

Cancer chemotherapy and pharmacology 19970101

Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.

American journal of clinical oncology 19961201

Ifosfamide encephalopathy and methylene-blue: a case report.

Annals of oncology : official journal of the European Society for Medical Oncology 19960801

Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.

Seminars in oncology 19960601

[The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic].

Terapevticheskii arkhiv 19960101

Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.

American journal of clinical oncology 19951201

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19950701

[Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].

Gan to kagaku ryoho. Cancer & chemotherapy 19950601

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study.

Annals of oncology : official journal of the European Society for Medical Oncology 19950201

Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma.

Haematologica 19940101

[Epileptic seizures and treatment with ifosfamide-mesna].

Revue neurologique 19940101

Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.

Cancer chemotherapy and pharmacology 19930101

Ifosfamide combination regimens for soft-tissue sarcoma.

Cancer chemotherapy and pharmacology 19930101

Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.

Cancer chemotherapy and pharmacology 19930101

Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease.

Leukemia & lymphoma 19921201

Oral ifosfamide-mesna: a clinical investigation in advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology 19921101

Encephalopathy in ifosfamide-treated patients.

Acta neurologica Scandinavica 19921101

An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma.

Investigational new drugs 19921101

Response of cyclophosphamide-resistant Wegener's granulomatosis to etoposide.

Lancet (London, England) 19920815

Mesna side effects which imitate vasculitis.

The Clinical investigator 19920801

Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.

Investigational new drugs 19920801

National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants.

Mayo Clinic proceedings 19920601

Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO).

Annals of oncology : official journal of the European Society for Medical Oncology 19920401

Primary tumour mutant p53 gene protein and epidermal growth factor receptor expression and doxorubicin plus ifosfamide for recurrent breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology 19920301

Hemorrhagic cystitis complicating bone marrow transplantation.

Mayo Clinic proceedings 19920201

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19920201

Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulin.

European journal of cancer (Oxford, England : 1990) 19920101

Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.

Gynecologic oncology 19911101

Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19911101

Allergic reactions to mesna.

Lancet (London, England) 19910914

Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Drugs 19910901

Allergic reactions to mesna.

Lancet (London, England) 19910810

Ifosfamide continuous infusion without mesna. A phase I trial of a 14-day cycle.

Cancer 19910215

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19910201

Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.

Journal of cancer research and clinical oncology 19910101

[Ifosfamide-induced urinary bladder lesion and its inhibition by mesna].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19900801

Ifosfamide with mesna uroprotection in the management of lung cancer.

American journal of clinical oncology 19900401

Ifosfamide and mesna.

Clinical pharmacy 19900301

Dana-Farber Cancer Institute studies in advanced sarcoma.

Seminars in oncology 19900201

Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion.

Annals of oncology : official journal of the European Society for Medical Oncology 19900101

Mesna excretion and ifosfamide nephrotoxicity in children.

Cancer research 19891215

Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma. The Gastrointestinal Tumor Study Group.

Cancer 19891115

Methyl-coenzyme-M reductase from Methanobacterium thermoautotrophicum (strain Marburg). Purity, activity and novel inhibitors.

European journal of biochemistry 19890901

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector.

Investigational new drugs 19890701

Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.

Arzneimittel-Forschung 19890601

Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.

Cancer research 19890101

Severe renal failure following high-dose ifosfamide and mesna.

Cancer chemotherapy and pharmacology 19890101

Drug-induced encephalopathy after previous ifosfamide treatment.

Lancet (London, England) 19881105

Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.

Lancet (London, England) 19880514

Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin.

Nihon Sanka Fujinka Gakkai zasshi 19880501

[Encephalopathy caused by an ifosfamide-mesna combination].

Presse medicale (Paris, France : 1983) 19880402

Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.

Medical and pediatric oncology 19880101

Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.

Bulletin du cancer 19880101

Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.

Medical and pediatric oncology 19880101

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19870801

Irreversible encephalopathy with ifosfamide/mesna.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19870801

The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19870501

Ifosfamide/mesna encephalopathy.

Lancet (London, England) 19870425

Ifosfamide neurotoxicity in children.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19870301

Encephalopathy with rapid infusion ifosfamide/mesna.

Lancet (London, England) 19870214

Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

Cancer treatment reports 19870201

Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.

Urologia internationalis 19870101

Blurring of vision due to ifosfamide.

Cancer chemotherapy and pharmacology 19870101

Avoiding ifosfamide/mesna encephalopathy.

Lancet (London, England) 19860816

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19860801

Prediction of ifosfamide/mesna associated encephalopathy.

European journal of cancer & clinical oncology 19860701

Phase II study of ifosfamide in cervical cancer.

Cancer treatment reports 19860601

The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.

Japanese journal of clinical oncology 19860601

CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 19860101

Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.

Cancer chemotherapy and pharmacology 19860101

Cause and prevention of mafosfamide-induced venous pain.

Investigational new drugs 19860101

Ifosfamide, mesna, and encephalopathy.

Lancet (London, England) 19850615

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.

Cancer treatment reports 19850501

Ifosfamide/mesa and encephalopathy.

Lancet (London, England) 19850330

Encephalopathy associated with ifosphamide/mesna therapy.

Lancet (London, England) 19850216

Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.

British journal of cancer 19841201

Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis.

Japanese journal of clinical oncology 19841201

Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.

European journal of cancer & clinical oncology 19841101

Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.

The Journal of urology 19840901

[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].

Der Urologe. Ausg. A 19840901

The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.

The Journal of urology 19840501

Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.

European journal of cancer & clinical oncology 19840301

Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.

Cancer treatment reviews 19830901

Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.

Cancer treatment reviews 19830901

Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).

Cancer 19830215

Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.

European journal of cancer & clinical oncology 19830201

[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].

Arzneimittel-Forschung 19820101

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.

Cancer chemotherapy and pharmacology 19820101

Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.

Blut 19811101

Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.

Journal of cancer research and clinical oncology 19810101

[Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].

Nowotwory 19810101

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.

Lancet (London, England) 19800927

[High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].

Schweizerische medizinische Wochenschrift 19791208